

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 6.95791622 |
| 2 | ADP metabolic process (GO:0046031) | 5.62180955 |
| 3 | response to muscle activity (GO:0014850) | 5.54254991 |
| 4 | positive regulation of catecholamine secretion (GO:0033605) | 5.52176786 |
| 5 | histone H3-K36 demethylation (GO:0070544) | 5.42677755 |
| 6 | cellular response to zinc ion (GO:0071294) | 5.27716018 |
| 7 | TOR signaling (GO:0031929) | 4.67798476 |
| 8 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.62504022 |
| 9 | regulation of autophagic vacuole assembly (GO:2000785) | 4.62371336 |
| 10 | coenzyme catabolic process (GO:0009109) | 4.60687074 |
| 11 | activation of protein kinase B activity (GO:0032148) | 4.59517110 |
| 12 | AMP metabolic process (GO:0046033) | 4.50083425 |
| 13 | parturition (GO:0007567) | 4.27760889 |
| 14 | myofibril assembly (GO:0030239) | 4.21295711 |
| 15 | oligosaccharide biosynthetic process (GO:0009312) | 4.12129960 |
| 16 | mRNA cleavage (GO:0006379) | 4.01997350 |
| 17 | regulation of oxidative stress-induced neuron death (GO:1903203) | 3.94815235 |
| 18 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.93861922 |
| 19 | cellular response to cadmium ion (GO:0071276) | 3.89831439 |
| 20 | muscle cell cellular homeostasis (GO:0046716) | 3.89070313 |
| 21 | regulation of oxidative phosphorylation (GO:0002082) | 3.79752560 |
| 22 | regulation of phospholipase A2 activity (GO:0032429) | 3.72748108 |
| 23 | regulation of myoblast differentiation (GO:0045661) | 3.67106917 |
| 24 | regulation of vacuole organization (GO:0044088) | 3.64694006 |
| 25 | regulation of skeletal muscle contraction (GO:0014819) | 3.64329553 |
| 26 | regulation of phosphoprotein phosphatase activity (GO:0043666) | 3.62564043 |
| 27 | positive regulation of protein kinase C signaling (GO:0090037) | 3.62427473 |
| 28 | energy homeostasis (GO:0097009) | 3.62217696 |
| 29 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.55042871 |
| 30 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 3.52842363 |
| 31 | purine nucleoside diphosphate metabolic process (GO:0009135) | 3.52842363 |
| 32 | motile cilium assembly (GO:0044458) | 3.52171783 |
| 33 | cGMP-mediated signaling (GO:0019934) | 3.46046378 |
| 34 | regulation of ARF GTPase activity (GO:0032312) | 3.45688089 |
| 35 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.45366534 |
| 36 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.37188037 |
| 37 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.32715298 |
| 38 | muscle fiber development (GO:0048747) | 3.29190479 |
| 39 | ganglioside metabolic process (GO:0001573) | 3.24880009 |
| 40 | phagocytosis, recognition (GO:0006910) | 3.15866216 |
| 41 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.08401015 |
| 42 | omega-hydroxylase P450 pathway (GO:0097267) | 3.07736420 |
| 43 | negative regulation of defense response to virus (GO:0050687) | 3.07493924 |
| 44 | radial glial cell differentiation (GO:0060019) | 3.07358161 |
| 45 | regulation of establishment of cell polarity (GO:2000114) | 3.02877145 |
| 46 | oligosaccharide catabolic process (GO:0009313) | 3.01993403 |
| 47 | positive regulation of release of sequestered calcium ion into cytosol (GO:0051281) | 2.99881133 |
| 48 | mannose metabolic process (GO:0006013) | 2.97250257 |
| 49 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.96623133 |
| 50 | mitochondrion degradation (GO:0000422) | 2.95718171 |
| 51 | diacylglycerol metabolic process (GO:0046339) | 2.93898572 |
| 52 | positive regulation of myoblast differentiation (GO:0045663) | 2.93531915 |
| 53 | cellular response to electrical stimulus (GO:0071257) | 2.92583779 |
| 54 | protein localization to cell surface (GO:0034394) | 2.90484687 |
| 55 | regulation of dopamine secretion (GO:0014059) | 2.88725984 |
| 56 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.87817503 |
| 57 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.87792322 |
| 58 | regulation of skeletal muscle fiber development (GO:0048742) | 2.87146053 |
| 59 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.83874734 |
| 60 | fibroblast migration (GO:0010761) | 2.83677085 |
| 61 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.81738119 |
| 62 | relaxation of smooth muscle (GO:0044557) | 2.81316555 |
| 63 | retinal cone cell development (GO:0046549) | 2.80058911 |
| 64 | response to zinc ion (GO:0010043) | 2.79243895 |
| 65 | negative regulation of macroautophagy (GO:0016242) | 2.79142719 |
| 66 | cellular response to lithium ion (GO:0071285) | 2.77322994 |
| 67 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.75246289 |
| 68 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.69043034 |
| 69 | sarcomere organization (GO:0045214) | 2.66515831 |
| 70 | establishment of mitotic spindle orientation (GO:0000132) | 2.66310674 |
| 71 | cellular response to toxic substance (GO:0097237) | 2.66159933 |
| 72 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.65621190 |
| 73 | cardiac muscle hypertrophy (GO:0003300) | 2.63136178 |
| 74 | androgen biosynthetic process (GO:0006702) | 2.62264031 |
| 75 | response to acidic pH (GO:0010447) | 2.60834240 |
| 76 | myelination in peripheral nervous system (GO:0022011) | 2.58410987 |
| 77 | peripheral nervous system axon ensheathment (GO:0032292) | 2.58410987 |
| 78 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.57392431 |
| 79 | positive regulation of protein homodimerization activity (GO:0090073) | 2.53564943 |
| 80 | regulation of protein kinase A signaling (GO:0010738) | 2.53308392 |
| 81 | tongue development (GO:0043586) | 2.52891917 |
| 82 | negative regulation of DNA binding (GO:0043392) | 2.52626861 |
| 83 | actin-mediated cell contraction (GO:0070252) | 2.50005101 |
| 84 | multicellular organism reproduction (GO:0032504) | 2.49723311 |
| 85 | regulation of protein kinase C signaling (GO:0090036) | 2.47911307 |
| 86 | striated muscle hypertrophy (GO:0014897) | 2.47653647 |
| 87 | cellular response to calcium ion (GO:0071277) | 2.47002034 |
| 88 | sialylation (GO:0097503) | 2.46311331 |
| 89 | actin-myosin filament sliding (GO:0033275) | 2.45572789 |
| 90 | muscle filament sliding (GO:0030049) | 2.45572789 |
| 91 | potassium ion export (GO:0071435) | 2.44256860 |
| 92 | cortical actin cytoskeleton organization (GO:0030866) | 2.44228133 |
| 93 | cofactor catabolic process (GO:0051187) | 2.43963188 |
| 94 | negative regulation of organelle assembly (GO:1902116) | 2.43622775 |
| 95 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.42810585 |
| 96 | cellular response to epinephrine stimulus (GO:0071872) | 2.41431010 |
| 97 | patterning of blood vessels (GO:0001569) | 2.38119038 |
| 98 | adaptation of signaling pathway (GO:0023058) | 2.36462574 |
| 99 | granulocyte differentiation (GO:0030851) | 2.35708921 |
| 100 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.34780004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 7.67410061 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.75026760 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.35915293 |
| 4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.78303689 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.72635548 |
| 6 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.72449928 |
| 7 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.58963834 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.56611045 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.54087745 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.34140707 |
| 11 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.31575612 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.11923148 |
| 13 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.04214363 |
| 14 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.95490753 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.88791363 |
| 16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87813301 |
| 17 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.71787330 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68856775 |
| 19 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.64989883 |
| 20 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.62361755 |
| 21 | VDR_22108803_ChIP-Seq_LS180_Human | 1.57391893 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.52031492 |
| 23 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.51024479 |
| 24 | RXR_22108803_ChIP-Seq_LS180_Human | 1.51004225 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41812001 |
| 26 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.40818199 |
| 27 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.40523610 |
| 28 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.35336947 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31581307 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.28098525 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.22288832 |
| 32 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21657675 |
| 33 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21657675 |
| 34 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17369034 |
| 35 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17369034 |
| 36 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.14511769 |
| 37 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.09470760 |
| 38 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07649138 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06883576 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06350758 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05959629 |
| 42 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.05153050 |
| 43 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.04270141 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04049259 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01806731 |
| 46 | TBL1_22424771_ChIP-Seq_293T_Human | 1.01573809 |
| 47 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00994072 |
| 48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00028112 |
| 49 | ERA_21632823_ChIP-Seq_H3396_Human | 0.99572202 |
| 50 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98362109 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.98095923 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.97948291 |
| 53 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.97671218 |
| 54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97577930 |
| 55 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96782725 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 0.96440915 |
| 57 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.95974532 |
| 58 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.95793659 |
| 59 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.95434876 |
| 60 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94841556 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94520685 |
| 62 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93892348 |
| 63 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93146379 |
| 64 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.92661364 |
| 65 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91470087 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91278573 |
| 67 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91102408 |
| 68 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91029336 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90811903 |
| 70 | CJUN_26792858_Chip-Seq_BT549_Human | 0.90764816 |
| 71 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.90620777 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.88283595 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87106610 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86407514 |
| 75 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.85503071 |
| 76 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.83498569 |
| 77 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.82469844 |
| 78 | CBP_21632823_ChIP-Seq_H3396_Human | 0.81691938 |
| 79 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.81592737 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.80745710 |
| 81 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.80205002 |
| 82 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80178396 |
| 83 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.78840141 |
| 84 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78097780 |
| 85 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78009500 |
| 86 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.77719780 |
| 87 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.77719780 |
| 88 | P300_19829295_ChIP-Seq_ESCs_Human | 0.77458193 |
| 89 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.77326023 |
| 90 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.76460922 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.74749797 |
| 92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.74136522 |
| 93 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.73877431 |
| 94 | GATA3_26560356_Chip-Seq_TH2_Human | 0.73857126 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.73748985 |
| 96 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73642312 |
| 97 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.73155862 |
| 98 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.72393593 |
| 99 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.71697554 |
| 100 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.71166442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.53693633 |
| 2 | MP0000749_muscle_degeneration | 4.17152047 |
| 3 | MP0004084_abnormal_cardiac_muscle | 3.48722092 |
| 4 | MP0001188_hyperpigmentation | 3.23238202 |
| 5 | MP0008004_abnormal_stomach_pH | 3.12218073 |
| 6 | MP0005409_darkened_coat_color | 3.10249715 |
| 7 | MP0003136_yellow_coat_color | 2.95034388 |
| 8 | MP0002132_abnormal_respiratory_system | 2.87603886 |
| 9 | MP0005647_abnormal_sex_gland | 2.79510268 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.71173758 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.69657708 |
| 12 | MP0005174_abnormal_tail_pigmentation | 2.57819889 |
| 13 | MP0010368_abnormal_lymphatic_system | 2.45535358 |
| 14 | MP0004036_abnormal_muscle_relaxation | 2.45505482 |
| 15 | MP0009697_abnormal_copulation | 2.43640863 |
| 16 | MP0005248_abnormal_Harderian_gland | 2.39944450 |
| 17 | MP0002638_abnormal_pupillary_reflex | 2.38612035 |
| 18 | MP0005330_cardiomyopathy | 2.33491765 |
| 19 | MP0004381_abnormal_hair_follicle | 2.15158125 |
| 20 | MP0001661_extended_life_span | 2.14675674 |
| 21 | MP0004484_altered_response_of | 2.08546278 |
| 22 | MP0009840_abnormal_foam_cell | 1.98170653 |
| 23 | MP0001919_abnormal_reproductive_system | 1.96590120 |
| 24 | MP0003315_abnormal_perineum_morphology | 1.84340278 |
| 25 | MP0002269_muscular_atrophy | 1.80864553 |
| 26 | MP0001502_abnormal_circadian_rhythm | 1.70068493 |
| 27 | MP0002108_abnormal_muscle_morphology | 1.67856342 |
| 28 | MP0000747_muscle_weakness | 1.60670342 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.54047057 |
| 30 | MP0002127_abnormal_cardiovascular_syste | 1.53182412 |
| 31 | MP0003828_pulmonary_edema | 1.48629086 |
| 32 | MP0005171_absent_coat_pigmentation | 1.48040008 |
| 33 | MP0001849_ear_inflammation | 1.46986780 |
| 34 | MP0004087_abnormal_muscle_fiber | 1.46323530 |
| 35 | MP0001664_abnormal_digestion | 1.44586736 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.38827872 |
| 37 | MP0005187_abnormal_penis_morphology | 1.33661843 |
| 38 | MP0004272_abnormal_basement_membrane | 1.33629492 |
| 39 | MP0002160_abnormal_reproductive_system | 1.33525099 |
| 40 | MP0005410_abnormal_fertilization | 1.33517034 |
| 41 | MP0003091_abnormal_cell_migration | 1.31626764 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.28723187 |
| 43 | MP0005389_reproductive_system_phenotype | 1.28636367 |
| 44 | MP0000759_abnormal_skeletal_muscle | 1.28212314 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.25663075 |
| 46 | MP0000751_myopathy | 1.25644450 |
| 47 | MP0001905_abnormal_dopamine_level | 1.25388842 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.25315462 |
| 49 | MP0005253_abnormal_eye_physiology | 1.24846917 |
| 50 | MP0005620_abnormal_muscle_contractility | 1.23352076 |
| 51 | MP0003632_abnormal_nervous_system | 1.21194040 |
| 52 | MP0003724_increased_susceptibility_to | 1.19737706 |
| 53 | MP0005451_abnormal_body_composition | 1.18797431 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.18528548 |
| 55 | MP0003646_muscle_fatigue | 1.17896440 |
| 56 | MP0004233_abnormal_muscle_weight | 1.17031405 |
| 57 | MP0003011_delayed_dark_adaptation | 1.16916455 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.09226472 |
| 59 | MP0001270_distended_abdomen | 1.08737428 |
| 60 | MP0004215_abnormal_myocardial_fiber | 1.06560837 |
| 61 | MP0005166_decreased_susceptibility_to | 1.05989485 |
| 62 | MP0006082_CNS_inflammation | 1.01537318 |
| 63 | MP0010386_abnormal_urinary_bladder | 1.00976332 |
| 64 | MP0003868_abnormal_feces_composition | 1.00652037 |
| 65 | MP0003385_abnormal_body_wall | 1.00370795 |
| 66 | MP0005646_abnormal_pituitary_gland | 1.00299371 |
| 67 | MP0001879_abnormal_lymphatic_vessel | 0.97585230 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 0.90510301 |
| 69 | MP0003879_abnormal_hair_cell | 0.85670746 |
| 70 | MP0001756_abnormal_urination | 0.84879258 |
| 71 | MP0000343_altered_response_to | 0.83404234 |
| 72 | MP0002877_abnormal_melanocyte_morpholog | 0.82979174 |
| 73 | MP0005595_abnormal_vascular_smooth | 0.81514380 |
| 74 | MP0005310_abnormal_salivary_gland | 0.80771873 |
| 75 | MP0005385_cardiovascular_system_phenoty | 0.80417827 |
| 76 | MP0001544_abnormal_cardiovascular_syste | 0.80417827 |
| 77 | MP0002139_abnormal_hepatobiliary_system | 0.77256499 |
| 78 | MP0002419_abnormal_innate_immunity | 0.76508047 |
| 79 | MP0001486_abnormal_startle_reflex | 0.73679390 |
| 80 | MP0003195_calcinosis | 0.73284870 |
| 81 | MP0009250_abnormal_appendicular_skeleto | 0.73032890 |
| 82 | MP0000013_abnormal_adipose_tissue | 0.72311137 |
| 83 | MP0010234_abnormal_vibrissa_follicle | 0.71766169 |
| 84 | MP0010630_abnormal_cardiac_muscle | 0.70761965 |
| 85 | MP0000537_abnormal_urethra_morphology | 0.68750014 |
| 86 | MP0000470_abnormal_stomach_morphology | 0.66648381 |
| 87 | MP0003631_nervous_system_phenotype | 0.64561133 |
| 88 | MP0000920_abnormal_myelination | 0.64155831 |
| 89 | MP0004130_abnormal_muscle_cell | 0.63982942 |
| 90 | MP0001984_abnormal_olfaction | 0.63418354 |
| 91 | MP0004019_abnormal_vitamin_homeostasis | 0.61043345 |
| 92 | MP0001835_abnormal_antigen_presentation | 0.60327405 |
| 93 | MP0006072_abnormal_retinal_apoptosis | 0.59944053 |
| 94 | MP0002115_abnormal_skeleton_extremities | 0.57610951 |
| 95 | MP0006036_abnormal_mitochondrial_physio | 0.57331197 |
| 96 | MP0005369_muscle_phenotype | 0.56258023 |
| 97 | MP0005551_abnormal_eye_electrophysiolog | 0.55824390 |
| 98 | MP0000733_abnormal_muscle_development | 0.55779600 |
| 99 | MP0005391_vision/eye_phenotype | 0.54855214 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 0.54226298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Clumsiness (HP:0002312) | 4.87108539 |
| 2 | Abnormality of the columella (HP:0009929) | 4.85899200 |
| 3 | Hyporeflexia of lower limbs (HP:0002600) | 4.70995056 |
| 4 | Reduced antithrombin III activity (HP:0001976) | 4.66878424 |
| 5 | Difficulty running (HP:0009046) | 4.54644637 |
| 6 | Cerebellar dysplasia (HP:0007033) | 4.37367814 |
| 7 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 4.00927629 |
| 8 | Diaphragmatic weakness (HP:0009113) | 3.90157630 |
| 9 | Exercise-induced myalgia (HP:0003738) | 3.87144525 |
| 10 | Dyschromatopsia (HP:0007641) | 3.80825006 |
| 11 | Scapular winging (HP:0003691) | 3.79139346 |
| 12 | Resting tremor (HP:0002322) | 3.68391149 |
| 13 | Eosinophilia (HP:0001880) | 3.65870888 |
| 14 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.54977059 |
| 15 | Bulbar palsy (HP:0001283) | 3.54551581 |
| 16 | Abnormality of the shoulder girdle musculature (HP:0001435) | 3.49442363 |
| 17 | Aortic aneurysm (HP:0004942) | 3.48750255 |
| 18 | Postural instability (HP:0002172) | 3.34057563 |
| 19 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 3.27464547 |
| 20 | Facial hemangioma (HP:0000329) | 3.27427876 |
| 21 | Adactyly (HP:0009776) | 3.21580834 |
| 22 | Muscular dystrophy (HP:0003560) | 3.17198086 |
| 23 | Abnormality of the frontal sinuses (HP:0002687) | 3.16045058 |
| 24 | Choroideremia (HP:0001139) | 3.15431830 |
| 25 | Hepatoblastoma (HP:0002884) | 3.08714409 |
| 26 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.05054614 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.02626637 |
| 28 | Facial diplegia (HP:0001349) | 2.95100697 |
| 29 | Aplasia cutis congenita (HP:0001057) | 2.93477526 |
| 30 | Enlarged kidneys (HP:0000105) | 2.86773475 |
| 31 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.84872049 |
| 32 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.84872049 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 2.84872049 |
| 34 | Granulocytopenia (HP:0001913) | 2.82748000 |
| 35 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.82026523 |
| 36 | Lower limb hyperreflexia (HP:0002395) | 2.77815712 |
| 37 | Thoracic kyphosis (HP:0002942) | 2.74035954 |
| 38 | Decreased central vision (HP:0007663) | 2.70633286 |
| 39 | Proximal amyotrophy (HP:0007126) | 2.70487228 |
| 40 | Spinal rigidity (HP:0003306) | 2.69626627 |
| 41 | Frequent falls (HP:0002359) | 2.67811988 |
| 42 | Hypophosphatemic rickets (HP:0004912) | 2.66185312 |
| 43 | EMG: myopathic abnormalities (HP:0003458) | 2.66009403 |
| 44 | Abnormality of the calf musculature (HP:0001430) | 2.65487024 |
| 45 | Popliteal pterygium (HP:0009756) | 2.65238189 |
| 46 | Increased variability in muscle fiber diameter (HP:0003557) | 2.64199871 |
| 47 | Ventricular fibrillation (HP:0001663) | 2.62694562 |
| 48 | Difficulty walking (HP:0002355) | 2.60735573 |
| 49 | Attenuation of retinal blood vessels (HP:0007843) | 2.58269980 |
| 50 | Abnormality of eosinophils (HP:0001879) | 2.57693651 |
| 51 | Short chin (HP:0000331) | 2.52323123 |
| 52 | Weak cry (HP:0001612) | 2.49538495 |
| 53 | Malignant hyperthermia (HP:0002047) | 2.46452563 |
| 54 | Poor head control (HP:0002421) | 2.42628170 |
| 55 | Abnormal protein glycosylation (HP:0012346) | 2.41675695 |
| 56 | Abnormal glycosylation (HP:0012345) | 2.41675695 |
| 57 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.41675695 |
| 58 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.41675695 |
| 59 | Partial agenesis of the corpus callosum (HP:0001338) | 2.38730909 |
| 60 | Calf muscle hypertrophy (HP:0008981) | 2.33183675 |
| 61 | Colitis (HP:0002583) | 2.28915414 |
| 62 | Prolonged partial thromboplastin time (HP:0003645) | 2.28668225 |
| 63 | Nonprogressive disorder (HP:0003680) | 2.25580255 |
| 64 | Alveolar cell carcinoma (HP:0006519) | 2.24833885 |
| 65 | Absent speech (HP:0001344) | 2.22403038 |
| 66 | Unsteady gait (HP:0002317) | 2.17430010 |
| 67 | High anterior hairline (HP:0009890) | 2.17048130 |
| 68 | Abnormal ciliary motility (HP:0012262) | 2.13743247 |
| 69 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.10374019 |
| 70 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.10294993 |
| 71 | Right ventricular cardiomyopathy (HP:0011663) | 2.10291321 |
| 72 | Ulnar bowing (HP:0003031) | 2.05676561 |
| 73 | Capillary hemangiomas (HP:0005306) | 2.05431265 |
| 74 | Easy fatigability (HP:0003388) | 2.03618331 |
| 75 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.01745883 |
| 76 | Neck muscle weakness (HP:0000467) | 1.99507734 |
| 77 | Renal cortical cysts (HP:0000803) | 1.99452481 |
| 78 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.98380578 |
| 79 | Foot dorsiflexor weakness (HP:0009027) | 1.97582465 |
| 80 | Rimmed vacuoles (HP:0003805) | 1.96477709 |
| 81 | Myopathic facies (HP:0002058) | 1.95153988 |
| 82 | Hyperkalemia (HP:0002153) | 1.93070692 |
| 83 | Genu recurvatum (HP:0002816) | 1.91681470 |
| 84 | Congenital hepatic fibrosis (HP:0002612) | 1.90466381 |
| 85 | Rhabdomyolysis (HP:0003201) | 1.87021182 |
| 86 | Sensory axonal neuropathy (HP:0003390) | 1.86843581 |
| 87 | Fetal akinesia sequence (HP:0001989) | 1.86683417 |
| 88 | Renal dysplasia (HP:0000110) | 1.86179226 |
| 89 | Thickened helices (HP:0000391) | 1.85957639 |
| 90 | Retinal atrophy (HP:0001105) | 1.85694642 |
| 91 | Hypoplasia of the thymus (HP:0000778) | 1.85193343 |
| 92 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.84067008 |
| 93 | Steppage gait (HP:0003376) | 1.83936382 |
| 94 | Atrioventricular block (HP:0001678) | 1.82741122 |
| 95 | Rib fusion (HP:0000902) | 1.80792373 |
| 96 | Basal ganglia calcification (HP:0002135) | 1.79332539 |
| 97 | Narrow palate (HP:0000189) | 1.78098689 |
| 98 | Overgrowth (HP:0001548) | 1.77746258 |
| 99 | Abnormality of the thoracic spine (HP:0100711) | 1.76918225 |
| 100 | Turricephaly (HP:0000262) | 1.76799415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 7.06812909 |
| 2 | MARK3 | 3.87994844 |
| 3 | OBSCN | 3.86275796 |
| 4 | MAP2K7 | 3.78798315 |
| 5 | PBK | 3.77179113 |
| 6 | LATS1 | 2.82788930 |
| 7 | BLK | 2.12180277 |
| 8 | ADRBK2 | 2.11870001 |
| 9 | NEK2 | 2.10090822 |
| 10 | MAPK15 | 2.03504621 |
| 11 | MAP3K6 | 1.98568771 |
| 12 | MAP3K13 | 1.94615746 |
| 13 | CSNK1A1L | 1.92157619 |
| 14 | CSNK1G1 | 1.76595286 |
| 15 | MYLK | 1.75282553 |
| 16 | FRK | 1.73159293 |
| 17 | CSNK1G3 | 1.62182644 |
| 18 | BMPR1B | 1.56664024 |
| 19 | TLK1 | 1.50467717 |
| 20 | MAP3K1 | 1.49078560 |
| 21 | NME2 | 1.46962720 |
| 22 | SGK494 | 1.36367364 |
| 23 | SGK223 | 1.36367364 |
| 24 | MAP3K4 | 1.36218591 |
| 25 | MOS | 1.27232526 |
| 26 | CSNK1G2 | 1.25993400 |
| 27 | IRAK2 | 1.25262622 |
| 28 | SGK2 | 1.15927677 |
| 29 | MUSK | 1.13196903 |
| 30 | LATS2 | 1.12228097 |
| 31 | TIE1 | 1.08236738 |
| 32 | STK38L | 1.06453648 |
| 33 | EEF2K | 1.06024730 |
| 34 | MAPK12 | 1.03486556 |
| 35 | PRKCQ | 1.01588389 |
| 36 | NLK | 1.01575434 |
| 37 | CDK3 | 1.00036105 |
| 38 | MAP3K5 | 0.98365987 |
| 39 | MELK | 0.96790899 |
| 40 | GRK6 | 0.88688319 |
| 41 | ZAK | 0.88198920 |
| 42 | SGK3 | 0.88094673 |
| 43 | ZAP70 | 0.87329854 |
| 44 | RET | 0.86520842 |
| 45 | RPS6KB1 | 0.85161312 |
| 46 | BTK | 0.83779326 |
| 47 | TGFBR1 | 0.75152982 |
| 48 | PRKG2 | 0.72627597 |
| 49 | PTK2B | 0.72030178 |
| 50 | FES | 0.70839982 |
| 51 | MAP3K9 | 0.70703821 |
| 52 | ARAF | 0.68427275 |
| 53 | TGFBR2 | 0.68293018 |
| 54 | STK38 | 0.67646075 |
| 55 | TRPM7 | 0.59454669 |
| 56 | MAP4K1 | 0.58732143 |
| 57 | CDC42BPA | 0.56292201 |
| 58 | CAMK1D | 0.53184978 |
| 59 | CDK12 | 0.51411445 |
| 60 | DYRK3 | 0.51171360 |
| 61 | MAP3K10 | 0.51052607 |
| 62 | ICK | 0.50030140 |
| 63 | PAK1 | 0.50017719 |
| 64 | SYK | 0.49989171 |
| 65 | GRK5 | 0.49538310 |
| 66 | RPS6KA4 | 0.49235259 |
| 67 | PDPK1 | 0.48535907 |
| 68 | MAP2K4 | 0.48185302 |
| 69 | RPS6KA2 | 0.47077839 |
| 70 | PDGFRB | 0.44933299 |
| 71 | FGFR2 | 0.44325269 |
| 72 | PRKD3 | 0.44086070 |
| 73 | CCNB1 | 0.42331838 |
| 74 | RPS6KA5 | 0.42230189 |
| 75 | DMPK | 0.41787268 |
| 76 | ROCK1 | 0.41372881 |
| 77 | DYRK2 | 0.41303479 |
| 78 | PKN2 | 0.38486097 |
| 79 | CSNK1D | 0.36873057 |
| 80 | MTOR | 0.35772802 |
| 81 | GRK1 | 0.34601597 |
| 82 | WNK1 | 0.34244502 |
| 83 | RPS6KC1 | 0.31925806 |
| 84 | RPS6KL1 | 0.31925806 |
| 85 | EGFR | 0.31582470 |
| 86 | CAMK4 | 0.31418184 |
| 87 | CAMK1 | 0.31343661 |
| 88 | RPS6KA6 | 0.30261397 |
| 89 | CSK | 0.30258299 |
| 90 | HCK | 0.29968779 |
| 91 | FGR | 0.29475918 |
| 92 | PHKG2 | 0.27953391 |
| 93 | PHKG1 | 0.27953391 |
| 94 | MAPK13 | 0.27326728 |
| 95 | PIK3CG | 0.27165098 |
| 96 | ADRBK1 | 0.26867379 |
| 97 | TRIB3 | 0.26372803 |
| 98 | ACVR1B | 0.25813674 |
| 99 | PRKAA1 | 0.25399237 |
| 100 | CSNK1A1 | 0.25257801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 5.32147117 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.67550139 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.83671553 |
| 4 | Circadian rhythm_Homo sapiens_hsa04710 | 2.16443474 |
| 5 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.12233093 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.04785605 |
| 7 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.80196687 |
| 8 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.76438546 |
| 9 | Renin secretion_Homo sapiens_hsa04924 | 1.73156050 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.55810651 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.47187230 |
| 12 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.46902176 |
| 13 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.44940807 |
| 14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.43784413 |
| 15 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.42340465 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35401452 |
| 17 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.32679546 |
| 18 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32595680 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.31964637 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.31591757 |
| 21 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.29361106 |
| 22 | Gap junction_Homo sapiens_hsa04540 | 1.16997393 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.15273089 |
| 24 | Phototransduction_Homo sapiens_hsa04744 | 1.12997585 |
| 25 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.12786321 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.11576373 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.11534566 |
| 28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.08159619 |
| 29 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06468524 |
| 30 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.04488296 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.03672804 |
| 32 | Melanogenesis_Homo sapiens_hsa04916 | 1.01916937 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.01541325 |
| 34 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.96964555 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.91681953 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 0.91162597 |
| 37 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.90722121 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.90389477 |
| 39 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.90228636 |
| 40 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.89840036 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89435137 |
| 42 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88332148 |
| 43 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.87517080 |
| 44 | Mineral absorption_Homo sapiens_hsa04978 | 0.87184527 |
| 45 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86968316 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 0.84036776 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.82596880 |
| 48 | Malaria_Homo sapiens_hsa05144 | 0.82144801 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.81536272 |
| 50 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80469569 |
| 51 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.80372093 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80086314 |
| 53 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77536018 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.77032505 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.75777498 |
| 56 | Melanoma_Homo sapiens_hsa05218 | 0.72763213 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.72120979 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70490772 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69731886 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69186881 |
| 61 | Long-term potentiation_Homo sapiens_hsa04720 | 0.68145072 |
| 62 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67555373 |
| 63 | Alcoholism_Homo sapiens_hsa05034 | 0.67457753 |
| 64 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.66089440 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65748706 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63774157 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62941721 |
| 68 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.62784626 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.61618330 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57096715 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56291560 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55981329 |
| 73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.55786199 |
| 74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.54518907 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.53727656 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.52889458 |
| 77 | Prostate cancer_Homo sapiens_hsa05215 | 0.50647736 |
| 78 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.50351183 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49804749 |
| 80 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49680908 |
| 81 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.48585720 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48339364 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46981474 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46779880 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46769307 |
| 86 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46527967 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.45479715 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45475369 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.43612846 |
| 90 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43417965 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42897073 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.42789366 |
| 93 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.42297222 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41906583 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39731201 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.39467631 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38396630 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38168528 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37155414 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36157357 |

